Product Name: Lornoxicam
Synonyms: LORNOXICAM;AKOS 93662;6-Chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide;LornoxicaM for injection;6-Chloro-4-hydroxy-2-Methyl-N-2-pyridinyl-;LornoxicaM API;6-Chloro-4-hydroxy-2-Methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxaMide;LornoxicaM (Xefo)
CAS: 70374-39-9
MF: C13H10ClN3O4S2
MW: 371.82
EINECS: 630-354-7
Product Categories: AVITA;Other APIs;APIs;Inhibitors;Fused Ring Systems;API;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;70374-39-9
Lornoxicam (Trade name: “Xefo”) belongs to a non-steroidal anti-inflammatory drug. As a kind of oxicam class drug, it has analgesic, anti-inflammatory and antipyretic properties. It can be used for the treatment of various type of acute mild to moderate pain which results from inflammatory diseases of the joints, osteoarthritis, surgery, sciatica and rheumatic diseases. Lornoxicam is capable of potently inhibiting the prostaglandin biosynthesis process, making it have highly pronounced efficacy. The exact mechanism of Lornoxicam is not exactly understood. However, it is indicated that Lornoxicam can inhibit the prostaglandin and thromboxane synthesis by inhibiting both COX-1 and COX-2, leading to reduction of inflammation, pain, fever, and swelling.
China
